三阴性乳腺癌患者的临床试验
总计12175个结果
-
Peter MacCallum Cancer Centre, AustraliaTrans Tasman Radiation Oncology Group完全的
-
Providence Health & ServicesMerck Sharp & Dohme LLC; Brooklyn ImmunoTherapeutics, LLC主动,不招人
-
Jiangsu HengRui Medicine Co., Ltd.终止
-
Queen Mary University of LondonHoffmann-La Roche; MedSIR; Westdeutsche Studiengruppe GmbH (WSG)主动,不招人
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University暂停
-
German Breast GroupAstraZeneca; Celgene完全的
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.未知
-
Mario Negri Institute for Pharmacological ResearchAssociazione Italiana per la Ricerca sul Cancro终止
-
University of VirginiaCelldex Therapeutics撤销
-
Hoffmann-La Roche完全的
-
Genentech, Inc.Hoffmann-La Roche完全的
-
Istituti Ospitalieri di Cremona未知
-
Cancer Institute and Hospital, Chinese Academy...Beijing Municipal Science & Technology Commission主动,不招人三阴性乳腺癌
-
Fudan UniversityZhejiang Cancer Hospital; Changhai Hospital; 307 Hospital of PLA; Sun Yat-sen University; The Affiliated... 和其他合作者完全的
-
Piramal Enterprises Limited终止
-
UNC Lineberger Comprehensive Cancer CenterIncyte Corporation撤销乳腺癌 | 乳腺肿瘤 | 三阴性乳腺癌 | HER2阳性乳腺癌
-
H. Lee Moffitt Cancer Center and Research InstituteKaryopharm Therapeutics Inc完全的
-
Massachusetts General HospitalTesaro, Inc.招聘中
-
Memorial Sloan Kettering Cancer CenterAstellas Pharma Inc; Medivation, Inc.主动,不招人
-
Memorial Sloan Kettering Cancer CenterCedars-Sinai Medical Center完全的
-
Kathy MillerGenentech, Inc.招聘中
-
Eisai Co., Ltd.完全的
-
National Cancer Institute (NCI)终止男性乳腺癌 | IV 期乳腺癌 | IIIA期乳腺癌 | IIIB期乳腺癌 | 三阴性乳腺癌 | IIIC期乳腺癌 | 复发性乳腺癌 | 雌激素受体阴性乳腺癌 | 孕激素受体阴性乳腺癌 | HER2 阴性乳腺癌加拿大
-
UNC Lineberger Comprehensive Cancer CenterBellicum Pharmaceuticals尚未招聘
-
Jo ChienMerck Sharp & Dohme LLC完全的
-
Kari WisinskiPfizer; Celcuity Inc主动,不招人
-
Dana-Farber Cancer Institute撤销
-
University of Southern CaliforniaNational Cancer Institute (NCI)撤销IV 期乳腺癌 | II期乳腺癌 | IIIA期乳腺癌 | IIIB期乳腺癌 | 三阴性乳腺癌 | IA期乳腺癌 | IB 期乳腺癌 | IIIC期乳腺癌 | 复发性乳腺癌
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)招聘中